Annual ROE
139.22%
+397.23%+153.96%
December 31, 2023
Summary
- As of February 8, 2025, FGEN annual return on equity is 139.22%, with the most recent change of +397.23% (+153.96%) on December 31, 2023.
- During the last 3 years, FGEN annual ROE has risen by +177.98% (+459.18%).
- FGEN annual ROE is now at all-time high.
Performance
FGEN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
53.64%
-28.29%-34.53%
September 30, 2024
Summary
- As of February 8, 2025, FGEN quarterly return on equity is 53.64%, with the most recent change of -28.29% (-34.53%) on September 30, 2024.
- Over the past year, FGEN quarterly ROE has stayed the same.
- FGEN quarterly ROE is now -84.97% below its all-time high of 356.85%, reached on September 30, 2023.
Performance
FGEN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
FGEN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +154.0% | 0.0% |
| 3 y3 years | +459.2% | 0.0% |
| 5 y5 years | +966.9% | 0.0% |
FGEN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +154.0% | -85.0% | +102.6% |
| 5 y | 5-year | at high | +154.0% | -85.0% | +102.6% |
| alltime | all time | at high | +154.0% | -85.0% | +102.6% |
FibroGen ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 53.64%(-34.5%) |
| Jun 2024 | - | 81.93%(-41.1%) |
| Mar 2024 | - | 139.05%(-37.3%) |
| Dec 2023 | 139.22%(-154.0%) | 221.86%(-37.8%) |
| Sep 2023 | - | 356.85%(-117.6%) |
| Jun 2023 | - | -2030.36%(+320.0%) |
| Mar 2023 | - | -483.45%(+89.5%) |
| Dec 2022 | -258.01%(+198.3%) | -255.06%(+30.1%) |
| Sep 2022 | - | -196.03%(+105.9%) |
| Jun 2022 | - | -95.22%(-3.8%) |
| Mar 2022 | - | -98.95%(+15.0%) |
| Dec 2021 | -86.50%(+123.2%) | -86.02%(+54.5%) |
| Sep 2021 | - | -55.66%(-3.9%) |
| Jun 2021 | - | -57.91%(+39.2%) |
| Mar 2021 | - | -41.61%(+2.9%) |
| Dec 2020 | -38.76%(+167.9%) | -40.44%(-11.2%) |
| Sep 2020 | - | -45.52%(-21.3%) |
| Jun 2020 | - | -57.84%(+193.0%) |
| Mar 2020 | - | -19.74%(+45.4%) |
| Dec 2019 | -14.47% | -13.58%(-279.9%) |
| Sep 2019 | - | 7.55%(-17.0%) |
| Jun 2019 | - | 9.10%(-151.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -17.66%(+6.3%) |
| Dec 2018 | -16.06%(-52.0%) | -16.62%(-37.4%) |
| Sep 2018 | - | -26.53%(+4.3%) |
| Jun 2018 | - | -25.43%(-20.5%) |
| Mar 2018 | - | -31.99%(-9.3%) |
| Dec 2017 | -33.44%(+7.1%) | -35.26%(-18.1%) |
| Sep 2017 | - | -43.03%(-27.6%) |
| Jun 2017 | - | -59.40%(+78.2%) |
| Mar 2017 | - | -33.34%(+10.0%) |
| Dec 2016 | -31.22%(-20.4%) | -30.30%(-21.8%) |
| Sep 2016 | - | -38.76%(-15.1%) |
| Jun 2016 | - | -45.66%(+47.5%) |
| Mar 2016 | - | -30.95%(-17.0%) |
| Dec 2015 | -39.21%(+14.7%) | -37.27%(-6.7%) |
| Sep 2015 | - | -39.94%(-2.7%) |
| Jun 2015 | - | -41.06%(-26.5%) |
| Mar 2015 | - | -55.90%(+40.4%) |
| Dec 2014 | -34.17%(+162.6%) | -39.82%(+32.7%) |
| Sep 2014 | - | -30.00%(-166.7%) |
| Jun 2014 | - | 44.98%(-1067.3%) |
| Mar 2014 | - | -4.65%(-129.6%) |
| Dec 2013 | -13.01%(-62.3%) | 15.72% |
| Dec 2012 | -34.47% | - |
FAQ
- What is FibroGen annual return on equity?
- What is the all time high annual ROE for FibroGen?
- What is FibroGen annual ROE year-on-year change?
- What is FibroGen quarterly return on equity?
- What is the all time high quarterly ROE for FibroGen?
- What is FibroGen quarterly ROE year-on-year change?
What is FibroGen annual return on equity?
The current annual ROE of FGEN is 139.22%
What is the all time high annual ROE for FibroGen?
FibroGen all-time high annual return on equity is 139.22%
What is FibroGen annual ROE year-on-year change?
Over the past year, FGEN annual return on equity has changed by +397.23% (+153.96%)
What is FibroGen quarterly return on equity?
The current quarterly ROE of FGEN is 53.64%
What is the all time high quarterly ROE for FibroGen?
FibroGen all-time high quarterly return on equity is 356.85%
What is FibroGen quarterly ROE year-on-year change?
Over the past year, FGEN quarterly return on equity has changed by 0.00% (0.00%)